Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Agenda Announced for the Annual Pharma CI USA Conference & ExhibitionProfessional gathering celebrates another meeting of industry influencers
Join Pharma CI for panel discussions, presentations, and networking events designed to engage the entire community and foster new business partnerships. It all takes place September 20-21 at the Newark Liberty International Airport Marriott Hotel. Event highlights include: 50+ Senior-Level Speakers 40+ Sessions (including "Ask The Experts" Roundtables, Masterclasses, Cocktail Reception and much more). Explore the timely topics and industry leaders that will headline this must-attend event. View the Agenda (http://pharmaciconference.com/ Reserve Your Spot & Save with the Early Rate (http://pharmaciconference.com/ We hope to see you at the Pharma CI USA Conference & Exhibition September 20 - 21 in Newark, New Jersey. The Pharma CI Conference includes the participation of the industry's leading companies, including: Abbott Laboratories, AbbVie, ADC Therapeutics, Amarin Pharma, AstraZeneca, Atacana Group, Bayer, BioMarin, Boehringer Ingelheim, Bristol Myers Squibb, Cambridge Healthcare Research, Datazymes, Day One Biopharmaceuticals, Deallus, Dig Worldwide, Eisai, Eli Lilly and Company, Evaluate, FENIX, Ferring, Fletcher/CSI, Gilead Sciences, INOVIS, inPhronesis, Intuitive Surgical, Ionis, Janssen, Johnson & Johnson, Kala Pharmaceuticals, Larvol, Lifescience Dynamics, Merck, Molekule Consulting, MorphoSys, Myriad Genetics, Northern Light, Novartis, Ozmosi, Pfizer, Prescient Healthcare Group, Teva, UCB, Zimmer Biomet, ZoomRX, and more! The Pharma CI Conference & Exhibition is the best and largest assembly of competitive intelligence executives in pharma, biotech, and medical devices for 15+ years. To register to attend the conference, go to: http://www.pharmaciconference.com/ For more information, call +1-212-228-7974 or email info@pharmaciconference.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|